Skip to content
10-Q

Quarterly Report

OMNI BIO PHARMACEUTICAL, INC.

0001437749-14-015302

← back to feed
Filed
Aug 13, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2015 · Aug 8, 2014 38.86M sh
Operating Cash Flow Q1 2015 · Jun 30, 2014 −$619.67K
Operating Cash Flow Q1 2015 · Jun 30, 2013 −$442.88K
Cash And Equivalents Q1 2015 · Jun 30, 2014 $651.76K
Cash And Equivalents Q1 2015 · Mar 31, 2014 $271.43K
Cash And Equivalents Q1 2015 · Jun 30, 2013 $1.26M
Cash And Equivalents Q1 2015 · Mar 31, 2013 $343.28K
Stockholders Equity Q1 2015 · Jun 30, 2014 −$981.82K
Stockholders Equity Q1 2015 · Mar 31, 2014 −$884.26K
Current Liabilities Q1 2015 · Jun 30, 2014 $473.29K
Current Liabilities Q1 2015 · Mar 31, 2014 $96.34K
Total Liabilities Q1 2015 · Jun 30, 2014 $1.94M
Total Liabilities Q1 2015 · Mar 31, 2014 $1.38M
Current Assets Q1 2015 · Jun 30, 2014 $793.56K
Current Assets Q1 2015 · Mar 31, 2014 $303.63K
Total Assets Q1 2015 · Jun 30, 2014 $959.4K
Total Assets Q1 2015 · Mar 31, 2014 $496.98K
Sga Expense Q1 2015 · Jun 30, 2014 $312.98K
Sga Expense Q1 2015 · Jun 30, 2013 $503.19K
Rd Expense Q1 2015 · Jun 30, 2014 $220.34K
Rd Expense Q1 2015 · Jun 30, 2013 $27.84K
Net Income Q1 2015 · Jun 30, 2014 −$833.7K
Net Income Q1 2015 · Jun 30, 2013 −$681.05K
Operating Income Q1 2015 · Jun 30, 2014 −$533.32K
Operating Income Q1 2015 · Jun 30, 2013 −$531.03K